Early Stage Venture Priothera Raises Series A of $35438833

October 11, 2020

About Priothera

Priothera is developing the orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies.

Website: Learn more on Priothera’s website

Crunchbase: Follow on Crunchbase

[adace-ad id=”4426″]

Series A – Priothera

Amount Raised30000000 EUR
Announced Date2020-10-12
Equity Only FundingYes
Organization LocationDublin, Dublin, Ireland, Europe
Funding StatusEarly Stage Venture
Number of Funding Rounds1
Lead InvestorsEarlybird Venture Capital, Fountain Healthcare Partners, HealthCap, Tekla Capital Management
Number of Investors4
Number of Partner Investors4